Alexion Pharmaceuticals, Inc.
Cerdulatinib for treating hematological cancers
Last updated:
Abstract:
Disclosed herein are methods and uses of cerdulatinib for treating diseases or conditions, including hematological cancers, and combinations of cerdulatinib for treating such diseases or conditions.
Status:
Grant
Type:
Utility
Filling date:
16 Jul 2020
Issue date:
20 Sep 2022